Viremia clinical trials

The registry lists 57 studies for Viremia across more than 10 countries. 12 are recruiting or about to start. 31 of them are mainly about Viremia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Viremia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 32
Recruiting: 10
Terminated: 5
Status unknown: 5
Active, not recruiting: 3
Not yet recruiting: 2

Phase

Phase 2: 13
Phase 4: 8
Phase 1: 7
Phase 3: 4
Early Phase 1: 2

Where

United States: 25
China: 7
Kenya: 3
France: 3
United Kingdom: 3
Puerto Rico: 2

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (9) · New Discovery LLC (2) · Indiana University (2) · University of California, San Francisco (2) · Peking University People's Hospital (2) · University College, London (2) · Washington University School of Medicine (1) · Emory University (1)

What is being tested here

Drugs under test in Viremia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Lamivudine	0	2
Valganciclovir	1	2
Ganciclovir	1	2
COVID-19 convalescent plasma	1	1
Dolutegravir	0	1
Abacavir	0	1
Indinavir	0	1
Saquinavir	0	1
Atorvastatin	0	1
Polysaccharide MGN3	0	1

Drug classes tested here Reverse transcriptase inhibitors 3

Coming up

0phase 3 studies under way

4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Feb 2027PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY · Centre for Infectious Disease Research in Zambia
Apr 2027CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency · University of Calgary
Jun 2027Long Acting Cabotegravir Plus Rilpivirine in People Living With HIV-1 Aged ≥ 60 Years for 24 Months. · Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Sep 2027Adaptability of an Undetectable = Untransmissible Model for HBV · NYU Langone Health

Who these studies take

Of the 10 Viremia studies recruiting now, 4 (40%) set no upper age limit and 4 (40%) stop at 75 or younger. 1 (10%) take children under 18. 1 (10%) are for women only and 0 (0%) for men only; 2 (20%) take healthy volunteers.

Recruiting studies that take each age, of 10
Age	Women	Men
10	0 (0%)	0 (0%)
18	10 (100%)	9 (90%)
30	10 (100%)	9 (90%)
40	10 (100%)	9 (90%)
50	10 (100%)	9 (90%)
65	10 (100%)	9 (90%)
75	8 (80%)	7 (70%)
85	6 (60%)	5 (50%)

Across all 57 studies, recruiting or not: 40% stop at 75 or younger and 33% at 65; 32% take children; 14% are for women only and 0% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

25BT056: Basket Study of Viral Cytotoxic T LymphocytesOct 14, 2026NCT07873970

Studies

Recruiting first, then most recently updated. Showing 50 of 57. Browse all 57 → or search them.